Class-Leading Service Provider & CRO for Bioanalysis

GLP and GMP certified, escorting clinical phases I-III,
preclinical phase and early stage investigation.

QUANTIFICATION
Assay development and validation of substances in plasma / urine / tissue at extremely high sensitivity (e.g. 250 fg/mL plasma).

IDENTIFICATION
Structure elucidation of unknown peaks:
Metabolite profiling, degradation products, side- & byproducts

INVESTIGATION
- Bioanalytical feasibilities (2-4 days)
- Tissue analysis
- Protein-binding (free vs. bound)
- Trouble shooting

BIOMARKERS
Discovery of biomarkers in plasma: Small Molecules & Peptides
Several Patents (Orphan Diseases)

May
pharm-analyt Obtains New Mass-Spec System API 6500 QTRAP®!

It´s with pride and excitement, that pharm-analyt announces the purchase of the new generation mass-spec-system API 6500 QTRAP® with SelexION system from AB Sciex!
Read more...

Feb.
Meet us at Bio-Europe Spring in Barcelona!

We are looking forward to meeting you at the highly effective partnering conference "Bio-Europe Spring 2013", held in Barcelona in the time between March 11-13th 2013!
Read more...

Jan.
Third European Patent for Biomarker Submitted!

After submitting european patents for lysosomal storage deseases in 2011 (Gaucher) and 2012 (NPC) in December last year we submitted another patent for ...
Read more...